title: Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT : part 1.
abstract: OBJECTIVE
  The goal of this article is to provide an overview of diagnostic standard operating procedures for both clinical and imaging assessment of cervical and endometrial carcinoma, sarcoma of the uterus, and primary pelvic non-Hodgkin's lymphoma.
  
  
  METHODS
  The literature was reviewed for methods used to diagnose malignancies in the female pelvis with a special focus on the role of MRI as the imaging method of choice. Furthermore, CT findings and staging criteria for the mentioned malignancies are also provided.
  
  
  CONCLUSIONS
  Whereas ultrasound still remains the imaging modality of choice in clinical practice for the early diagnosis of female pelvic malignancies, MRI is more frequently recognized as a diagnostic tool for its accuracy in tumor identification. MRI also plays a crucial role in the 3D pretreatment planning for brachytherapy especially in cervical cancer. In the future, PET/CT might achieve an important role for staging lymph nodes or distant metastases as well as tumor recurrence.
authors.affiliation: Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Germany. kerstin.brocker@med.uni-heidelberg.de
authors.forename: Kerstin A
authors.initials: KA
authors.lastname: Brocker
authors.forename: Celine D
authors.initials: CD
authors.lastname: Alt
authors.forename: Michael
authors.initials: M
authors.lastname: Eichbaum
authors.forename: Christof
authors.initials: C
authors.lastname: Sohn
authors.forename: Hans-Ulrich
authors.initials: HU
authors.lastname: Kauczor
authors.forename: Peter
authors.initials: P
authors.lastname: Hallscheidt
mesh_terms: D016889:Endometrial Neoplasms / Q000175:diagnosis / Q000473:pathology; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008207:Lymphatic Metastasis / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000473:pathology; D008279:Magnetic Resonance Imaging; D064847:Multimodal Imaging; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D010386:Pelvic Neoplasms / Q000175:diagnosis* / Q000473:pathology; D049268:Positron-Emission Tomography; D011379:Prognosis; D012509:Sarcoma / Q000175:diagnosis / Q000473:pathology; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000473:pathology; D014594:Uterine Neoplasms / Q000175:diagnosis / Q000473:pathology